Similar articles

• [Pharmacokinetics of a combination of magnesium-chlorophenoxy-isobutyrate and meso-inositol hexanicotinate].

  Paltauf F, Pristautz H, el Eisch IA. Paltauf F, et al. Acta Med Austriaca. 1977;4(3):120-4. Acta Med Austriaca. 1977. PMID: 930544 German.
• Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs.

  Schurr PE, Schultz JR, Parkinson TM. Schurr PE, et al. Lipids. 1972 Jan;7(1):68-74. doi: 10.1007/BF02531272. Lipids. 1972. PMID: 5013174 No abstract available.
• Animal models for screening hypolipidemic drugs. III. The response of nicotinic acid and clofibrate in fed and fasted old rats.

  Magnusson O, Andersson I, Nordlund L. Magnusson O, et al. Z Versuchstierkd. 1978;20(1):46-58. Z Versuchstierkd. 1978. PMID: 636683 No abstract available.
• The effect of hypolipidemic drugs on plasma lipoproteins.

  Levy RI. Levy RI. Annu Rev Pharmacol Toxicol. 1977;17:499-510. doi: 10.1146/annurev.pa.17.040177.002435. Annu Rev Pharmacol Toxicol. 1977. PMID: 326171 Review. No abstract available.
• Clinical pharmacokinetics of hypolipidaemic drugs.

  Gugler R. Gugler R. Clin Pharmacokinet. 1978 Nov-Dec;3(6):425-39. doi: 10.2165/00003088-197803060-00001. Clin Pharmacokinet. 1978. PMID: 363332 Review. No abstract available.